← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2004-09-10

Drug application

FDA Application #
ANDA076372
Application type
Abbreviated New Drug Application (Generic)
Brand name
BRIMONIDINE TARTRATE
Generic name
Brimonidine Tartrate
Active ingredients
BRIMONIDINE TARTRATE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
TEVA PARENTERAL
First approval
2004-09-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown